|

Restrospective Analysis of MACE in Patients Treated With Drug-elluting Balloons.

RECRUITINGSponsored by Olivier F. Bertrand
Actively Recruiting
SponsorOlivier F. Bertrand
Started2025-06-10
Est. completion2035-12
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06972225

Summary

Retrospective analysis of data collected in an institutional database of coronary interventions with use of drug-eluting balloons, with a prospective follow-up for major adverse cardiovascular events and living status.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Adults (\>=18 years of age)
* Who underwent a coronary angioplasty with drug-eluting balloon between January 2010 and December 2025
* Identified in the institutional procedure database

Exclusion Criteria:

* Incomplete or non-available data on the post-procedural clinical follow-up
* Procedures where other devices were used in combination with drug-eluting balloons.

Conditions4

Bifurcation Coronary DiseaseCoronary Arterial Disease (CAD)Heart DiseaseRestenosis, Coronary

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.